Pharmaceutical

ICR to enter AI-powered cancer drug discovery partnership

Scientists at the ICR, London are set to enter a partnership to merge capabilities for designing precision drugs for cancer leveraging AI.

Jul 13, 2023 - 20:00
ICR to enter AI-powered cancer drug discovery partnership
Scientists at the ICR, London are set to enter a partnership to merge capabilities for designing precision drugs for cancer leveraging AI.
Read the original article

Tags:

Previous Article

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

Next Article

Opdivo by Bristol Myers Shows Positive Results in Phase 3 Trial for Bladder Canc...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines

STAT+: Viking Therapeutics obesity drug hits target in ...

Feb 27, 2024

Vanda acquires rights to Actelion’s multiple sclerosis drug

Vanda acquires rights to Actelion’s multiple sclerosis ...

Dec 8, 2023

FDA approves Madrigal’s Rezdiffra as the first NASH therapy

FDA approves Madrigal’s Rezdiffra as the first NASH the...

Mar 16, 2024